Organophosphorous compound poisoning : prolonged therapy in absence of intermediate neurotoxic syndrome.
Sheth
S G
SG
Department of Medicine, T.N.Medical College, Bombay.
Mahe
S C
SC
Hakim
A S
AS
Mehta
P J
PJ
Soneji
S L
SL
D000328:Adult; D001285:Atropine / Q000008:administration & dosage / Q000627:therapeutic use; D002800:Cholinesterase Inhibitors / Q000506:poisoning*; D002801:Cholinesterase Reactivators / Q000008:administration & dosage / Q000627:therapeutic use; D003976:Diazinon / Q000506:poisoning*; D005207:Fasciculation / Q000139:chemically induced / Q000188:drug therapy; D005500:Follow-Up Studies; D006801:Humans; D007306:Insecticides / Q000506:poisoning*; D008297:Male; D018727:Muscarinic Antagonists / Q000008:administration & dosage / Q000627:therapeutic use; D062025:Organophosphate Poisoning; D010243:Paralysis / Q000517:prevention & control*; D010575:Pesticides / Q000506:poisoning*; D011220:Pralidoxime Compounds / Q000008:administration & dosage / Q000627:therapeutic use
D002800:Cholinesterase Inhibitors; D002801:Cholinesterase Reactivators; D007306:Insecticides; D018727:Muscarinic Antagonists; D010575:Pesticides; D011220:Pralidoxime Compounds; D001285:Atropine; D003976:Diazinon